Poly Medicure Delivers Strong Q2 FY27 Revenue Growth Driven by International Expansion
Poly Medicure Ltd 路 Investor Presentation 路 05 Nov 2026, 8:14 pm
Poly Medicure Delivers Strong Q2 FY27 Revenue Growth Driven by International Expansion Poly Medicure reported a 30.8% YoY rise in consolidated Q2 FY27 revenue to Rs 580.5 crore (organic growth at 16.3%), supported by 35.0% YoY growth in international sales and 22.0% in domestic markets. Consolidated operating EBITDA grew 20.1% YoY to Rs 139.1 crore with a 24.0% margin, while PAT rose 3.6% YoY to Rs 95.1 crore. Non-infusion segments expanded to 51% of revenue in H1 FY27. Liquidity remained robust with Rs 839.1 crore in cash and cash equivalents as of 30th Sep'26.
Original exchange filing (PDF)
More announcements from Poly Medicure Ltd
- Enclosed 路 13 Nov 2026
- Enclosed 路 11 Nov 2026
- Please find enclosed herewith Monitoring Agency Report for the quarter ended September 30, 2026. 路 07 Nov 2026
- Please find enclosed herewith intimation of revision of policies and/or code of conduct of the company 路 05 Nov 2026
- Please find enclose statement of deviation(s) or variation(s). 路 05 Nov 2026
- Enclosed 路 05 Nov 2026
- Please find enclosed outcome of the board meeting. 路 05 Nov 2026
- Poly Medicure Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 05 Nov 2026
